Marvel Biosciences' CEO is Rod Matheson, appointed in Jul 2021, has a tenure of 4.83 years. total yearly compensation is CA$150.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 8.38% of the company’s shares, worth $611.87K. The average tenure of the management team and the board of directors is 4.8 years and 4.5 years respectively.
Key information
Rod Matheson
Chief executive officer
CA$150.0k
Total compensation
CEO salary percentage
100.00%
CEO tenure
4.8yrs
CEO ownership
8.4%
Management average tenure
4.8yrs
Board average tenure
4.5yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Rod Matheson's remuneration changed compared to Marvel Biosciences's earnings?
Date
Total Compensation
Salary
Company Earnings
Jan 31 2026
n/a
n/a
-CA$2m
Oct 31 2025
n/a
n/a
-CA$2m
Jul 31 2025
CA$150k
CA$150k
-CA$2m
Apr 30 2025
n/a
n/a
-CA$2m
Jan 31 2025
n/a
n/a
-CA$2m
Oct 31 2024
n/a
n/a
-CA$1m
Jul 31 2024
CA$150k
CA$150k
-CA$2m
Apr 30 2024
n/a
n/a
-CA$2m
Jan 31 2024
n/a
n/a
-CA$3m
Oct 31 2023
n/a
n/a
-CA$3m
Jul 31 2023
CA$150k
CA$150k
-CA$2m
Apr 30 2023
n/a
n/a
-CA$2m
Jan 31 2023
n/a
n/a
-CA$2m
Oct 31 2022
n/a
n/a
-CA$2m
Jul 31 2022
CA$150k
CA$150k
-CA$3m
Apr 30 2022
n/a
n/a
-CA$4m
Jan 31 2022
n/a
n/a
-CA$4m
Oct 31 2021
n/a
n/a
-CA$3m
Jul 31 2021
CA$147k
CA$147k
-CA$3m
Apr 30 2021
n/a
n/a
-CA$1m
Jan 31 2021
n/a
n/a
-CA$1m
Oct 31 2020
n/a
n/a
-CA$1m
Jul 31 2020
CA$77k
CA$77k
-CA$956k
Compensation vs Market: Rod's total compensation ($USD108.58K) is below average for companies of similar size in the US market ($USD627.03K).
Compensation vs Earnings: Rod's compensation has been consistent with company performance over the past year.
CEO
Rod Matheson
4.8yrs
Tenure
CA$150,000
Compensation
Mr. J. Roderick Matheson, also known as Rod, serves as Chief Executive Officer & Director at Marvel Biosciences Corp. since June 14, 2021 and served as its President and serves as its Executive Chairman. H...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
J. Matheson
Executive Chairman & CEO
4.8yrs
CA$150.00k
8.38% $ 611.9k
Mark Williams
President
4.8yrs
CA$150.00k
7.93% $ 579.1k
Harpreet Nijjar
Chief Financial Officer
4.3yrs
CA$84.00k
no data
Jacqueline Groot
Corporate Secretary
4.8yrs
no data
no data
4.8yrs
Average Tenure
Experienced Management: MBCO.F's management team is considered experienced (4.8 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
J. Matheson
Executive Chairman & CEO
4.9yrs
CA$150.00k
8.38% $ 611.9k
Mark Williams
President
4.9yrs
CA$150.00k
7.93% $ 579.1k
Neil Johnson
Lead Independent Director
4.9yrs
CA$10.00k
0.33% $ 23.7k
Babak Pedram
Independent Director
3.5yrs
CA$10.00k
0.27% $ 19.7k
Randall Smallbone
Independent Director
4.3yrs
CA$10.00k
no data
David Blum
Member of Scientific Advisory Board
4.5yrs
no data
no data
Jared Young
Member of Scientific Advisory Board
4.5yrs
no data
no data
Bruce Cronstein
Member of Scientific Advisory Board
4.5yrs
no data
no data
Frank Schweizer
Member of Scientific Advisory Board
4.5yrs
no data
no data
4.5yrs
Average Tenure
52yo
Average Age
Experienced Board: MBCO.F's board of directors are considered experienced (4.5 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/24 12:44
End of Day Share Price
2026/05/21 00:00
Earnings
2026/01/31
Annual Earnings
2025/07/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Marvel Biosciences Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.